Connect-HCTD

Understanding Life with Hereditary Connective Tissue Disorders
A patient-oriented research program

About the Project

Living with a hereditary connective tissue disorder (HCTD), such as Loeys-Dietz syndrome, Marfan syndrome or Ehlers-Danlos syndrome, often means navigating a complex healthcare system while managing a condition that affects many aspects of everyday life.

Although these conditions are lifelong and multisystemic, little is known about how people experience them over time, how healthcare fits within their lives, and where important gaps in care remain.

This research program seeks to better understand the lived experience of people with hereditary connective tissue disorders and to generate knowledge and tools that can improve care, support patients and families, and inform healthcare professionals and decision-makers.

The project is conducted in partnership with patients, clinicians, researchers and patient organizations, including the Loeys-Dietz Syndrome Foundation Canada.

Research Objectives

This research program is organized around three complementary objectives.

Objective 1
Understanding clinical guidance

The first phase consists of a systematic review of international clinical practice guidelines for Marfan syndrome, Loeys-Dietz syndrome and Ehlers-Danlos syndromes.

This review aims to:

  • identify existing recommendations for diagnosis, treatment and symptom management;
  • evaluate the methodological quality of available clinical guidelines;
  • examine patient involvement in guideline development;
  • identify important evidence gaps that may limit high-quality care.

Consult here the complete database on clinical recommendations: https://airtable.com/app3S29kg3K6e7DLw/shrkCQX1WXWTV8Mdu

Objective 2
Understanding the lifecourse of people living with a hereditary connective tissue disorder

Through narrative interviews and life-course mapping, this project seeks to understand how living with a hereditary connective tissue disorder unfolds across time.

The research explores:

  • how symptoms appear, evolve and are managed throughout life;
  • how healthcare experiences interact with education, work, family life, relationships and other life domains;
  • how barriers to care emerge and change across different stages of life.

Rather than studying healthcare alone, this project examines the broader life journey of people living with these conditions.

If you are an adult patient who received healthcare in Canada with a diagnosis of Loeys-Dietz, Marfan, or Ehlers-Danlos syndrome, we are currently recruiting: https://redcap.link/thtc

Objective 3
Identifying opportunities to improve care

Building on participants’ life-course maps, the final phase aims to identify where healthcare systems can better support people living with hereditary connective tissue disorders.

More specifically, the project seeks to:

  • identify unmet needs throughout the life course;
  • understand where patients encounter obstacles within the healthcare system;
  • identify strategies that could reduce these barriers;
  • determine the most appropriate moments across the life course for interventions and support.

Ultimately, the goal is to contribute to more coordinated, patient-partenered evidence-informed care, that will lead to an app acting like a roadmap to navigate the life with the condition and to access resources timely.

A Partnership Approach

People living with hereditary connective tissue disorders are partners throughout this research.

Patients, caregivers, clinicians and community organizations contribute to:

  • identifying research priorities;
  • refining research questions;
  • interpreting findings;
  • co-developing future resources and knowledge translation tools.

Their lived experience is considered an essential source of expertise.

From Research to Action

This project is designed to generate practical resources that can directly benefit the hereditary connective tissue disorder community.

Planned knowledge translation activities include:

  • a comprehensive database of clinical recommendations;
  • plain-language summaries of research findings;
  • visual maps illustrating the life journey with hereditary connective tissue disorders;
  • recommendations for improving healthcare services;
  • a bilingual Patient Learning Pathway co-developed with patients and clinicians to support disease understanding, healthcare navigation and self-management.
  • conferences addressed to patients, caregivers and clinicians

Get Involved

There will be several opportunities to contribute throughout the project.

You can:

  • participate as a research participant;
  • participate in the co-creation of knowledge translation tools;
  • stay informed through project updates.

Together, we hope to build tools that reflect the realities and priorities of people living with hereditary connective tissue disorders.

Research Team

Project coordinator :

Catherine Côté, M.Sc.
Doctoral Candidate in Clinical Psychology
Université de Montréal
Centre de recherche du CHUM

Co-investigators

Dr Hance Clarke
Audrey L’Espérance
Dre Anne-Marie Laberge
Anaïs Lacasse
Dre Marie-Pascale Pomey
Matthew Menear

 

Principal investigator

Gabrielle Pagé, Ph.D.
Université de Montréal
Centre de recherche du CHUM

Collaborators

Dre Camille Laflamme. 
Elise Develay

Patient partners

Annie-Danielle Grenier
Sylvie Beaudoin
Mizaël Bilodeau

Community partners

Loeys-Dietz Syndrome Foundation Canada
Centre of Excellence on Partnership with Patients and the Public (https://ceppp.ca)
EDS Canada Foundation (https://edscanada.org)
Genetic Aortic Disorders Association Canada (GADA) (https://www.gadacanada.ca)
Constellation – Troubles héréditaires du tissu conjonctif (https://www.facebook.com/constellationthtc)

Funding

Titre: Vivre avec une maladie complexe, multisystémique et douloureuse : Cartographier le parcours de vie avec un trouble héréditaire du tissu conjonctif pour développer un parcours d’apprentissage patients. 

Investigatrice principale: Gabrielle Pagé
Candidats principaux : Annie-Danielle Grenier
Co-investigateurs: Mizaël Bilodeau, Dr Hance Clarke, Catherine Côté, Audrey L’Espérance, Dre Anne-Marie Laberge, Anaïs Lacasse, Dre Marie-Pascale Pomey, Matthew Menear
Collaborateurs : Elise Develay, Dre Camille Laflamme. 
Financement: 397 800$. Subvention Projet des Instituts de recherche en santé du Canada
Comité : Recherche en interventions et en évaluation dans les services de santé 2 (HS2)

Titre: Hereditary Connective Tissue Disorder: Reviewing existing clinical guidelines and co-constructing the first stage of a patient mapping journey.

Investigatrice principale: Gabrielle Pagé
Co-investigateurs: Catherine Côté, Annie-Danielle Grenier, Caroline Hébert, Dr Hance Clarke, Audrey L’Espérance, Anaïs Lacasse, Dre Marie-Pascale Pomey
Collaborateurs: Mizaël Bilodeau, Elise Develay, Dre Anne-Marie Laberge, Dre Camille Laflamme.
Financement: 50 000 $.  Subvention de planification et de dissémination – Programme d’appui communautaire des instituts de recherche en santé du Canada. 2024-2025.

Titre : Soutenir l’autogestion, l’organisation et l’intégration des soins : développement et implémentation d’un parcours d’apprentissage patient pour les troubles héréditaires du tissu conjonctif

Financement : 50 000$
Année : 2026
Programme : Bourse d’impact sur le système de santé – Instituts de recherche en santé du Canada (IRSC)

Contact

For questions about the project or opportunities to participate, please contact:
Catherine Côté : catherine.cote.13@umontreal.ca
Subscribe to our newsletter to receive updates on CONNECT-HCTD: https://mailchi.mp/fea8157d7177/pcp

Scroll to Top